Cardiopulmonary interventions |
#Blood_transfusion_red blood cell; treatment codes: 1 = Control; 2 = ANH; 3 = ANH_Hypotension; 4 = ANH_Lowcentral venous pressure; 5 = Lowcentral venous pressure. |
list(nt=5,ns=6) |
y[,1] |
se[,1] |
y[,2] |
se[,2] |
y[,3] |
se[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
1.6625 |
0.2 |
0.4175 |
0.16 |
0 |
0.01 |
1 |
2 |
3 |
3 |
#Yao 2006
|
0.8775 |
0.05 |
1.145 |
0.12 |
NA |
NA |
1 |
4 |
NA |
2 |
#Guo 2013
|
2.75 |
0.4 |
1.3 |
0.075 |
NA |
NA |
1 |
5 |
NA |
2 |
#El‐Kharboutly 2004
|
3.215 |
0.58 |
1.3125 |
0.12 |
NA |
NA |
1 |
5 |
NA |
2 |
#Wang 2006
|
0.44 |
0.37 |
0.7 |
0.35 |
NA |
NA |
4 |
5 |
NA |
2 |
#Jarnagin 2008
|
0 |
0.47 |
0 |
0.47 |
NA |
NA |
4 |
5 |
NA |
2 |
#Matot 2002
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Blood_loss; treatment codes: 1 = Control; 2 = ANH; 3 = ANH_Hypotension; 4 = ANH_Lowcentral venous pressure; 5 = Hypoventilation; 6 = Lowcentral venous pressure. |
list(nt=6,ns=9) |
y[,1] |
se[,1] |
y[,2] |
se[,2] |
y[,3] |
se[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
0.651 |
0.01 |
0.654 |
0.05 |
0.404 |
0.06 |
1 |
2 |
3 |
3 |
#Yao 2006
|
0.711 |
0.02 |
0.735 |
0.02 |
NA |
NA |
1 |
4 |
NA |
2 |
#Guo 2013
|
0.63 |
0.41 |
0.63 |
0.4 |
NA |
NA |
1 |
5 |
NA |
2 |
#Hasegawa 2002
|
0.783 |
0.08 |
0.589 |
0.07 |
NA |
NA |
1 |
6 |
NA |
2 |
#Choi 2007
|
1.021 |
0.07 |
0.49 |
0.06 |
NA |
NA |
1 |
6 |
NA |
2 |
#El‐Kharboutly 2004
|
0.584 |
0.1 |
0.499 |
0.1 |
NA |
NA |
1 |
6 |
NA |
2 |
#Kato 2008
|
2.329 |
0.51 |
0.904 |
0.04 |
NA |
NA |
1 |
6 |
NA |
2 |
#Wang 2006
|
0.8 |
0.09 |
0.7 |
0.09 |
NA |
NA |
4 |
6 |
NA |
2 |
#Jarnagin 2008
|
0.75 |
0.41 |
0.89 |
0.41 |
NA |
NA |
4 |
6 |
NA |
2 |
#Matot 2002
|
END |
|
|
|
|
|
|
|
|
|
|
|
Methods of parenchymal transection |
#Adverse_events_proportion; treatment codes: 1 = ClampCrush; 2 = cavitron ultrasonic surgical aspirator; 3 = Hydrojet; 4 = RFDS; 5 = SharpTransection; 6 = Stapler. |
list(nt=6,ns=8) |
|
|
|
|
|
|
|
|
|
r[,1] |
n[,1] |
r[,2] |
n[,2] |
r[,3] |
n[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
15 |
20 |
7 |
20 |
10 |
20 |
1 |
2 |
4 |
3 |
#Doklestic 2012
|
17 |
25 |
25 |
25 |
NA |
NA |
1 |
2 |
NA |
2 |
#Koo 2005
|
14 |
66 |
20 |
66 |
NA |
NA |
1 |
2 |
NA |
2 |
#Takayama 2001
|
7 |
40 |
9 |
40 |
NA |
NA |
1 |
4 |
NA |
2 |
#Arita 2005
|
17 |
50 |
18 |
50 |
NA |
NA |
1 |
4 |
NA |
2 |
#Muratore 2014
|
16 |
41 |
17 |
41 |
NA |
NA |
1 |
5 |
NA |
2 |
#Smyrniotis 2005
|
30 |
65 |
31 |
65 |
NA |
NA |
1 |
6 |
NA |
2 |
#Rahbari 2014
|
8 |
30 |
3 |
31 |
NA |
NA |
2 |
3 |
NA |
2 |
#Rau 2001
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Adverse_events_number; treatment codes: 1 = ClampCrush; 2 = Cavitron ultrasonic surgical aspirator; 3 = Hydrojet; 4 = RFDS; 5 = SharpTransection; 6 = Stapler. |
list(nt=6,ns=7) |
r[,1] |
E[,1] |
r[,2] |
E[,2] |
r[,3] |
E[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
16 |
66 |
25 |
66 |
NA |
NA |
1 |
2 |
NA |
2 |
#Takayama 2001
|
7 |
40 |
9 |
40 |
NA |
NA |
1 |
4 |
NA |
2 |
#Arita 2005
|
11 |
60 |
15 |
60 |
NA |
NA |
1 |
4 |
NA |
2 |
#Ikeda 2009
|
2 |
26 |
12 |
24 |
NA |
NA |
1 |
4 |
NA |
2 |
#Lupo 2007
|
16 |
41 |
18 |
41 |
NA |
NA |
1 |
5 |
NA |
2 |
#Smyrniotis 2005
|
8 |
25 |
7 |
25 |
9 |
25 |
2 |
3 |
4 |
3 |
#Lesurtel 2005
|
19 |
50 |
22 |
50 |
NA |
NA |
2 |
6 |
NA |
2 |
#Savlid 2013
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Blood_transfusion_proportion; treatment codes: 1 = ClampCrush; 2 = Cavitron ultrasonic surgical aspirator; 3 = Hydrojet; 4 = RFDS; 5 = SharpTransection. |
list(nt=5,ns=8) |
r[,1] |
n[,1] |
r[,2] |
n[,2] |
r[,3] |
n[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
2 |
20 |
3 |
20 |
4 |
20 |
1 |
2 |
4 |
3 |
#Doklestic 2012
|
1 |
66 |
1 |
66 |
NA |
NA |
1 |
2 |
NA |
2 |
#Takayama 2001
|
0 |
40 |
2 |
40 |
NA |
NA |
1 |
4 |
NA |
2 |
#Arita 2005
|
2 |
60 |
2 |
60 |
NA |
NA |
1 |
4 |
NA |
2 |
#Ikeda 2009
|
13 |
26 |
8 |
24 |
NA |
NA |
1 |
4 |
NA |
2 |
#Lupo 2007
|
13 |
50 |
16 |
50 |
NA |
NA |
1 |
4 |
NA |
2 |
#Muratore 2014
|
15 |
41 |
13 |
41 |
NA |
NA |
1 |
5 |
NA |
2 |
#Smyrniotis 2005
|
8 |
25 |
8 |
25 |
5 |
25 |
2 |
3 |
4 |
3 |
#Lesurtel 2005
|
END |
|
|
|
|
|
|
|
|
|
|
|
Methods of vascular occlusion |
#Serious_adverse_events_proportion; treatment codes: 1 = Control; 2 = ConHVE; 3 = ConPTC; 4 = ConSelectiveHVE; 5 = ConSelectivePTC; 6 = IntPTC. |
list(nt=6,ns=8) |
|
|
|
|
|
|
|
|
|
r[,1] |
n[,1] |
r[,2] |
n[,2] |
r[,3] |
n[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
4 |
63 |
2 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Capussotti 2006
|
9 |
63 |
14 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Lee 2012
|
2 |
25 |
1 |
25 |
NA |
NA |
1 |
6 |
NA |
2 |
#Park 2012
|
3 |
60 |
2 |
58 |
NA |
NA |
2 |
3 |
NA |
2 |
#Chen 2006
|
2.5 |
81 |
0.5 |
81 |
NA |
NA |
3 |
4 |
NA |
2 |
#Si‐Yuan 2014
|
22 |
60 |
12 |
60 |
NA |
NA |
3 |
5 |
NA |
2 |
#Ni 2013
|
4 |
18 |
2 |
17 |
NA |
NA |
3 |
6 |
NA |
2 |
#Capussotti 2003
|
1 |
40 |
4 |
40 |
NA |
NA |
5 |
6 |
NA |
2 |
#Liang 2009
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Adverse_events_proportion; treatment codes: 1 = Control; 2 = ConHVE; 3 = ConPTC; 4 = ConSelectiveHVE; 5 = ConSelectivePTC; 6 = IntPTC; 7 = IntSelectivePTC. |
list(nt=7,ns=12) |
r[,1] |
n[,1] |
r[,2] |
n[,2] |
r[,3] |
n[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
16 |
63 |
21 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Capussotti 2006
|
15 |
63 |
26 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Lee 2012
|
15 |
50 |
13 |
50 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 1997
|
9 |
20 |
5 |
20 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 2003
|
19 |
60 |
17 |
58 |
NA |
NA |
2 |
3 |
NA |
2 |
#Chen 2006
|
17 |
80 |
9 |
80 |
NA |
NA |
3 |
4 |
NA |
2 |
#Si‐Yuan 2014
|
24 |
60 |
13 |
60 |
NA |
NA |
3 |
5 |
NA |
2 |
#Ni 2013
|
13 |
42 |
11 |
44 |
NA |
NA |
3 |
6 |
NA |
2 |
#Belghiti 1999
|
4 |
18 |
2 |
17 |
NA |
NA |
3 |
6 |
NA |
2 |
#Capussotti 2003
|
9 |
40 |
8 |
40 |
NA |
NA |
5 |
6 |
NA |
2 |
#Liang 2009
|
15 |
39 |
12 |
41 |
NA |
NA |
6 |
7 |
NA |
2 |
#Figueras 2005
|
8 |
28 |
10 |
30 |
NA |
NA |
6 |
7 |
NA |
2 |
#Wu 2002
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Blood_transfusion_proportion; treatment codes: 1 = Control; 2 = ConHVE; 3 = ConPTC; 4 = ConSelectiveHVE; 5 = ConSelectivePTC; 6 = IntPTC; 7 = IntSelectivePTC. |
list(nt=7,ns=13) |
r[,1] |
n[,1] |
r[,2] |
n[,2] |
r[,3] |
n[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
6 |
15 |
1 |
19 |
NA |
NA |
1 |
3 |
NA |
2 |
#Chouker 2004
|
1 |
63 |
8 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Capussotti 2006
|
9 |
63 |
14 |
63 |
NA |
NA |
1 |
6 |
NA |
2 |
#Lee 2012
|
29 |
50 |
18 |
50 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 1997
|
19 |
20 |
12 |
20 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 2003
|
8 |
60 |
27 |
58 |
NA |
NA |
2 |
3 |
NA |
2 |
#Chen 2006
|
22 |
80 |
13 |
80 |
NA |
NA |
3 |
4 |
NA |
2 |
#Si‐Yuan 2014
|
4 |
60 |
6 |
60 |
NA |
NA |
3 |
5 |
NA |
2 |
#Ni 2013
|
12 |
42 |
14 |
44 |
NA |
NA |
3 |
6 |
NA |
2 |
#Belghiti 1999
|
5 |
18 |
5 |
17 |
NA |
NA |
3 |
6 |
NA |
2 |
#Capussotti 2003
|
15 |
40 |
14 |
40 |
NA |
NA |
5 |
6 |
NA |
2 |
#Liang 2009
|
4 |
39 |
6 |
41 |
NA |
NA |
6 |
7 |
NA |
2 |
#Figueras 2005
|
12 |
28 |
5 |
30 |
NA |
NA |
6 |
7 |
NA |
2 |
#Wu 2002
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Blood_transfusion_red blood cell; treatment codes: 1 = Control; 2 = ConHVE; 3 = ConPTC; 4 = ConSelectiveHVE; 5 = ConSelectivePTC; 6 = IntPTC; 7 = IntSelectivePTC. |
list(nt=7,ns=10) |
y[,1] |
se[,1] |
y[,2] |
se[,2] |
y[,3] |
se[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
1.9 |
1.02 |
1.3 |
0.85 |
NA |
NA |
1 |
3 |
NA |
2 |
#Clavien 1996
|
1.5 |
0.45 |
0 |
0.45 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 1997
|
2.5 |
0.64 |
2.9 |
0.8 |
NA |
NA |
2 |
3 |
NA |
2 |
#Belghiti 1996
|
2.2 |
0.42 |
1 |
0.42 |
NA |
NA |
3 |
4 |
NA |
2 |
#Si‐Yuan 2014
|
1.4 |
0.05 |
1.2 |
0.03 |
NA |
NA |
3 |
5 |
NA |
2 |
#Ni 2013
|
3 |
0.4 |
2.3 |
0.39 |
NA |
NA |
3 |
6 |
NA |
2 |
#Belghiti 1999
|
0.5 |
0.02 |
0.5 |
0.27 |
NA |
NA |
3 |
6 |
NA |
2 |
#Capussotti 2003
|
1.3675 |
0.09 |
1.4825 |
0.15 |
NA |
NA |
5 |
6 |
NA |
2 |
#Liang 2009
|
0.36 |
0.16 |
0.34 |
0.14 |
NA |
NA |
6 |
7 |
NA |
2 |
#Figueras 2005
|
2.5425 |
0.26 |
2.24 |
0.4 |
NA |
NA |
6 |
7 |
NA |
2 |
#Wu 2002
|
END |
|
|
|
|
|
|
|
|
|
|
|
#Blood_loss; treatment codes: 1 = Control; 2 = ConHVE; 3 = ConPTC; 4 = ConSelectiveHVE; 5 = ConSelectivePTC; 6 = IntPTC; 7 = IntSelectivePTC. |
list(nt=7,ns=16) |
y[,1] |
se[,1] |
y[,2] |
se[,2] |
y[,3] |
se[,3] |
t[,1] |
t[,2] |
t[,3] |
na[] |
#study |
2.17 |
0.22 |
1.38 |
0.16 |
NA |
NA |
1 |
3 |
NA |
2 |
#Chouker 2004
|
0.32 |
0.05 |
0.328 |
0.02 |
NA |
NA |
1 |
3 |
NA |
2 |
#Dayangac 2010
|
0.671 |
0.32 |
0.65 |
0.16 |
NA |
NA |
1 |
3 |
NA |
2 |
#Pietsch 2010
|
0.204 |
0.02 |
0.184 |
0.03 |
NA |
NA |
1 |
6 |
NA |
2 |
#Capussotti 2006
|
0.489 |
0.06 |
0.488 |
0.07 |
NA |
NA |
1 |
6 |
NA |
2 |
#Lee 2012
|
1.99 |
0.18 |
1.28 |
0.18 |
NA |
NA |
1 |
6 |
NA |
2 |
#Man 1997
|
0.324 |
0.03 |
0.486 |
0.06 |
NA |
NA |
1 |
6 |
NA |
2 |
#Park 2012
|
1.195 |
0.21 |
0.989 |
0.26 |
NA |
NA |
2 |
3 |
NA |
2 |
#Belghiti 1996
|
0.42 |
0.03 |
0.77 |
0.04 |
NA |
NA |
2 |
3 |
NA |
2 |
#Chen 2006
|
0.777 |
0.09 |
0.529 |
0.09 |
NA |
NA |
3 |
4 |
NA |
2 |
#Si‐Yuan 2014
|
0.2 |
0.1 |
0.3 |
0.1 |
NA |
NA |
3 |
5 |
NA |
2 |
#Ni 2013
|
1.18 |
0.12 |
1.29 |
0.14 |
NA |
NA |
3 |
6 |
NA |
2 |
#Belghiti 1999
|
0.733 |
0.12 |
0.732 |
0.15 |
NA |
NA |
3 |
6 |
NA |
2 |
#Capussotti 2003
|
0.649 |
0.04 |
0.57 |
0.05 |
NA |
NA |
5 |
6 |
NA |
2 |
#Liang 2009
|
0.671 |
0.09 |
0.735 |
0.06 |
NA |
NA |
6 |
7 |
NA |
2 |
#Figueras 2005
|
1.685 |
0.17 |
1.159 |
0.22 |
NA |
NA |
6 |
7 |
NA |
2 |
#Wu 2002
|
END |